ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Colorectal Cancer Diagnostics & Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-16Q14216
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Colorectal Cancer Diagnostics Therapeutics Market Research Report 2023
BUY CHAPTERS

Colorectal Cancer Diagnostics & Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-16Q14216
Report
October 2024
Pages:152
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina Inc
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Taiho Pharma
Merck KGaA
Amgen Inc
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx

Colorectal Cancer Diagnostics & Therapeutics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Colorectal Cancer Diagnostics & Therapeutics - Market

Colorectal Cancer Diagnostics & Therapeutics - Market

Colorectal Cancer Diagnostics & Therapeutics refer to the tools, techniques, and treatments aimed at identifying and managing colorectal cancer, a type of cancer that originates in the colon or rectum. Diagnostics include screening methods like colonoscopy, stool tests, and imaging scans to detect the presence of cancerous growths. Therapeutics involve a range of treatments such as surgery, chemotherapy, radiation therapy, targeted therapies, and immunotherapy, all tailored to the stage and characteristics of the cancer to improve patient outcomes and quality of life.
The global market for Colorectal Cancer Diagnostics & Therapeutics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Diagnostics & Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Colorectal Cancer Diagnostics & Therapeutics by region & country, by Type, and by Application.
The Colorectal Cancer Diagnostics & Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Diagnostics & Therapeutics.
Market Segmentation

Scope of Colorectal Cancer Diagnostics & Therapeutics - Market Report

Report Metric Details
Report Name Colorectal Cancer Diagnostics & Therapeutics - Market
CAGR 5%
Segment by Type:
  • Colorectal Cancer Diagnostics
  • Colorectal Cancer Therapeutics
Segment by Application
  • Hospitals
  • Specialty Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biocept, Cancer Genetics, Foundation Medicine, Sysmex Corporation, Danaher Corporation, Epigenomics, Illumina, Rosetta Genomics, Exact Science Corporation, Pathway Genomics Corporation, Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron, Bayer, Onyx
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Colorectal Cancer Diagnostics & Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Colorectal Cancer Diagnostics & Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Colorectal Cancer Diagnostics & Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Colorectal Cancer Diagnostics & Therapeutics - Market report?

Ans: The main players in the Colorectal Cancer Diagnostics & Therapeutics - Market are Biocept, Cancer Genetics, Foundation Medicine, Sysmex Corporation, Danaher Corporation, Epigenomics, Illumina, Rosetta Genomics, Exact Science Corporation, Pathway Genomics Corporation, Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron, Bayer, Onyx

What are the Application segmentation covered in the Colorectal Cancer Diagnostics & Therapeutics - Market report?

Ans: The Applications covered in the Colorectal Cancer Diagnostics & Therapeutics - Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Colorectal Cancer Diagnostics & Therapeutics - Market report?

Ans: The Types covered in the Colorectal Cancer Diagnostics & Therapeutics - Market report are Colorectal Cancer Diagnostics, Colorectal Cancer Therapeutics

1 Market Overview
1.1 Colorectal Cancer Diagnostics & Therapeutics Product Introduction
1.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Forecast
1.3 Colorectal Cancer Diagnostics & Therapeutics Market Trends & Drivers
1.3.1 Colorectal Cancer Diagnostics & Therapeutics Industry Trends
1.3.2 Colorectal Cancer Diagnostics & Therapeutics Market Drivers & Opportunity
1.3.3 Colorectal Cancer Diagnostics & Therapeutics Market Challenges
1.3.4 Colorectal Cancer Diagnostics & Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Colorectal Cancer Diagnostics & Therapeutics Players Revenue Ranking (2023)
2.2 Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Colorectal Cancer Diagnostics & Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Colorectal Cancer Diagnostics & Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Colorectal Cancer Diagnostics & Therapeutics
2.6 Colorectal Cancer Diagnostics & Therapeutics Market Competitive Analysis
2.6.1 Colorectal Cancer Diagnostics & Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Colorectal Cancer Diagnostics
3.1.2 Colorectal Cancer Therapeutics
3.2 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type
3.2.1 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Others
4.2 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application
4.2.1 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Region
5.1.1 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
5.2.2 North America Colorectal Cancer Diagnostics & Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
5.3.2 Europe Colorectal Cancer Diagnostics & Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
5.5.2 South America Colorectal Cancer Diagnostics & Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Colorectal Cancer Diagnostics & Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Colorectal Cancer Diagnostics & Therapeutics Sales Value
6.3 United States
6.3.1 United States Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
6.3.2 United States Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
6.4.2 Europe Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
6.5.2 China Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
6.6.2 Japan Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019-2030
6.9.2 India Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biocept
7.1.1 Biocept Profile
7.1.2 Biocept Main Business
7.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.1.4 Biocept Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Biocept Recent Developments
7.2 Cancer Genetics
7.2.1 Cancer Genetics Profile
7.2.2 Cancer Genetics Main Business
7.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.2.4 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Cancer Genetics Recent Developments
7.3 Foundation Medicine
7.3.1 Foundation Medicine Profile
7.3.2 Foundation Medicine Main Business
7.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.3.4 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Sysmex Corporation Recent Developments
7.4 Sysmex Corporation
7.4.1 Sysmex Corporation Profile
7.4.2 Sysmex Corporation Main Business
7.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.4.4 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 Sysmex Corporation Recent Developments
7.5 Danaher Corporation
7.5.1 Danaher Corporation Profile
7.5.2 Danaher Corporation Main Business
7.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.5.4 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Danaher Corporation Recent Developments
7.6 Epigenomics
7.6.1 Epigenomics Profile
7.6.2 Epigenomics Main Business
7.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.6.4 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 Epigenomics Recent Developments
7.7 Illumina
7.7.1 Illumina Profile
7.7.2 Illumina Main Business
7.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.7.4 Illumina Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Illumina Recent Developments
7.8 Rosetta Genomics
7.8.1 Rosetta Genomics Profile
7.8.2 Rosetta Genomics Main Business
7.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.8.4 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 Rosetta Genomics Recent Developments
7.9 Exact Science Corporation
7.9.1 Exact Science Corporation Profile
7.9.2 Exact Science Corporation Main Business
7.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.9.4 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 Exact Science Corporation Recent Developments
7.10 Pathway Genomics Corporation
7.10.1 Pathway Genomics Corporation Profile
7.10.2 Pathway Genomics Corporation Main Business
7.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.10.4 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Pathway Genomics Corporation Recent Developments
7.11 Taiho Pharma
7.11.1 Taiho Pharma Profile
7.11.2 Taiho Pharma Main Business
7.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.11.4 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Taiho Pharma Recent Developments
7.12 Merck KGaA
7.12.1 Merck KGaA Profile
7.12.2 Merck KGaA Main Business
7.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.12.4 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 Merck KGaA Recent Developments
7.13 Amgen
7.13.1 Amgen Profile
7.13.2 Amgen Main Business
7.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.13.4 Amgen Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Amgen Recent Developments
7.14 Takeda
7.14.1 Takeda Profile
7.14.2 Takeda Main Business
7.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.14.4 Takeda Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 Takeda Recent Developments
7.15 Roche
7.15.1 Roche Profile
7.15.2 Roche Main Business
7.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.15.4 Roche Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.15.5 Roche Recent Developments
7.16 Eli Lilly
7.16.1 Eli Lilly Profile
7.16.2 Eli Lilly Main Business
7.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.16.4 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.16.5 Eli Lilly Recent Developments
7.17 Sanofi
7.17.1 Sanofi Profile
7.17.2 Sanofi Main Business
7.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.17.4 Sanofi Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.17.5 Sanofi Recent Developments
7.18 Regeneron
7.18.1 Regeneron Profile
7.18.2 Regeneron Main Business
7.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.18.4 Regeneron Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.18.5 Regeneron Recent Developments
7.19 Bayer
7.19.1 Bayer Profile
7.19.2 Bayer Main Business
7.19.3 Bayer Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.19.4 Bayer Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.19.5 Bayer Recent Developments
7.20 Onyx
7.20.1 Onyx Profile
7.20.2 Onyx Main Business
7.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
7.20.4 Onyx Colorectal Cancer Diagnostics & Therapeutics Revenue (US$ Million) & (2019-2024)
7.20.5 Onyx Recent Developments
8 Industry Chain Analysis
8.1 Colorectal Cancer Diagnostics & Therapeutics Industrial Chain
8.2 Colorectal Cancer Diagnostics & Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Colorectal Cancer Diagnostics & Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Colorectal Cancer Diagnostics & Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina Inc
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Taiho Pharma
Merck KGaA
Amgen Inc
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
List of Tables
    Table 1. Colorectal Cancer Diagnostics & Therapeutics Market Trends
    Table 2. Colorectal Cancer Diagnostics & Therapeutics Market Drivers & Opportunity
    Table 3. Colorectal Cancer Diagnostics & Therapeutics Market Challenges
    Table 4. Colorectal Cancer Diagnostics & Therapeutics Market Restraints
    Table 5. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Colorectal Cancer Diagnostics & Therapeutics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Colorectal Cancer Diagnostics & Therapeutics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Colorectal Cancer Diagnostics & Therapeutics
    Table 10. Global Colorectal Cancer Diagnostics & Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Colorectal Cancer Diagnostics & Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Colorectal Cancer Diagnostics & Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Colorectal Cancer Diagnostics & Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Colorectal Cancer Diagnostics & Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Colorectal Cancer Diagnostics & Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Colorectal Cancer Diagnostics & Therapeutics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Colorectal Cancer Diagnostics & Therapeutics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Biocept Basic Information List
    Table 32. Biocept Description and Business Overview
    Table 33. Biocept Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Biocept (2019-2024)
    Table 35. Biocept Recent Developments
    Table 36. Cancer Genetics Basic Information List
    Table 37. Cancer Genetics Description and Business Overview
    Table 38. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Cancer Genetics (2019-2024)
    Table 40. Cancer Genetics Recent Developments
    Table 41. Foundation Medicine Basic Information List
    Table 42. Foundation Medicine Description and Business Overview
    Table 43. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Foundation Medicine (2019-2024)
    Table 45. Foundation Medicine Recent Developments
    Table 46. Sysmex Corporation Basic Information List
    Table 47. Sysmex Corporation Description and Business Overview
    Table 48. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Sysmex Corporation (2019-2024)
    Table 50. Sysmex Corporation Recent Developments
    Table 51. Danaher Corporation Basic Information List
    Table 52. Danaher Corporation Description and Business Overview
    Table 53. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Danaher Corporation (2019-2024)
    Table 55. Danaher Corporation Recent Developments
    Table 56. Epigenomics Basic Information List
    Table 57. Epigenomics Description and Business Overview
    Table 58. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Epigenomics (2019-2024)
    Table 60. Epigenomics Recent Developments
    Table 61. Illumina Basic Information List
    Table 62. Illumina Description and Business Overview
    Table 63. Illumina Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Illumina (2019-2024)
    Table 65. Illumina Recent Developments
    Table 66. Rosetta Genomics Basic Information List
    Table 67. Rosetta Genomics Description and Business Overview
    Table 68. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Rosetta Genomics (2019-2024)
    Table 70. Rosetta Genomics Recent Developments
    Table 71. Exact Science Corporation Basic Information List
    Table 72. Exact Science Corporation Description and Business Overview
    Table 73. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Exact Science Corporation (2019-2024)
    Table 75. Exact Science Corporation Recent Developments
    Table 76. Pathway Genomics Corporation Basic Information List
    Table 77. Pathway Genomics Corporation Description and Business Overview
    Table 78. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Pathway Genomics Corporation (2019-2024)
    Table 80. Pathway Genomics Corporation Recent Developments
    Table 81. Taiho Pharma Basic Information List
    Table 82. Taiho Pharma Description and Business Overview
    Table 83. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Taiho Pharma (2019-2024)
    Table 85. Taiho Pharma Recent Developments
    Table 86. Merck KGaA Basic Information List
    Table 87. Merck KGaA Description and Business Overview
    Table 88. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Merck KGaA (2019-2024)
    Table 90. Merck KGaA Recent Developments
    Table 91. Amgen Basic Information List
    Table 92. Amgen Description and Business Overview
    Table 93. Amgen Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Amgen (2019-2024)
    Table 95. Amgen Recent Developments
    Table 96. Takeda Basic Information List
    Table 97. Takeda Description and Business Overview
    Table 98. Takeda Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Takeda (2019-2024)
    Table 100. Takeda Recent Developments
    Table 101. Roche Basic Information List
    Table 102. Roche Description and Business Overview
    Table 103. Roche Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Roche (2019-2024)
    Table 105. Roche Recent Developments
    Table 106. Eli Lilly Basic Information List
    Table 107. Eli Lilly Description and Business Overview
    Table 108. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Eli Lilly (2019-2024)
    Table 110. Eli Lilly Recent Developments
    Table 111. Sanofi Basic Information List
    Table 112. Sanofi Description and Business Overview
    Table 113. Sanofi Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Sanofi (2019-2024)
    Table 115. Sanofi Recent Developments
    Table 116. Regeneron Basic Information List
    Table 117. Regeneron Description and Business Overview
    Table 118. Regeneron Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Regeneron (2019-2024)
    Table 120. Regeneron Recent Developments
    Table 121. Bayer Basic Information List
    Table 122. Bayer Description and Business Overview
    Table 123. Bayer Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Bayer (2019-2024)
    Table 125. Bayer Recent Developments
    Table 126. Onyx Basic Information List
    Table 127. Onyx Description and Business Overview
    Table 128. Onyx Colorectal Cancer Diagnostics & Therapeutics Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Colorectal Cancer Diagnostics & Therapeutics Business of Onyx (2019-2024)
    Table 130. Onyx Recent Developments
    Table 131. Key Raw Materials Lists
    Table 132. Raw Materials Key Suppliers Lists
    Table 133. Colorectal Cancer Diagnostics & Therapeutics Downstream Customers
    Table 134. Colorectal Cancer Diagnostics & Therapeutics Distributors List
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
    Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Colorectal Cancer Diagnostics & Therapeutics Product Picture
    Figure 2. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Colorectal Cancer Diagnostics & Therapeutics Report Years Considered
    Figure 5. Global Colorectal Cancer Diagnostics & Therapeutics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2023
    Figure 7. Colorectal Cancer Diagnostics & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Colorectal Cancer Diagnostics Picture
    Figure 9. Colorectal Cancer Therapeutics Picture
    Figure 10. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospitals
    Figure 13. Product Picture of Specialty Clinics
    Figure 14. Product Picture of Others
    Figure 15. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Colorectal Cancer Diagnostics & Therapeutics Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Colorectal Cancer Diagnostics & Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Colorectal Cancer Diagnostics & Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Colorectal Cancer Diagnostics & Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Colorectal Cancer Diagnostics & Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Colorectal Cancer Diagnostics & Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Colorectal Cancer Diagnostics & Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Colorectal Cancer Diagnostics & Therapeutics Sales Value (%), (2019-2030)
    Figure 28. United States Colorectal Cancer Diagnostics & Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Colorectal Cancer Diagnostics & Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Colorectal Cancer Diagnostics & Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Colorectal Cancer Diagnostics & Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Colorectal Cancer Diagnostics & Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Colorectal Cancer Diagnostics & Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Colorectal Cancer Diagnostics & Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Colorectal Cancer Diagnostics & Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 49. Colorectal Cancer Diagnostics & Therapeutics Industrial Chain
    Figure 50. Colorectal Cancer Diagnostics & Therapeutics Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Colorectal Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Targeted Drugs for Colorectal Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Metastatic Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Colon Cancer Molecular Diagnostics Market Research Report 2024
Global Colorectal Cancer Molecular Diagnostics Market Research Report 2024
In Vitro Colorectal Cancer Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Colorectal Cancer Screening Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Melanoma Diagnostics and Therapeutics Market Research Report 2024
Global Colorectal Cancer Test Kit Market Research Report 2025
Global Emerging Cancer Diagnostics Market Research Report 2024
Global Colorectal Surgery Devices Market Research Report 2024
Global Molecular Diagnosis of Rectal Cancer Market Research Report 2024
Melanoma Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Research Report 2024
Cancer Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cervical Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Colorectal Capsule Endoscopy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rectal Cancer Therapeutics Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions
OSZAR »